ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2284

Epigenetic Profiling in Monozygotic Twins Discordant for Systemic Lupus Erythematosus Reveals Prominent Hypomethylation of Interferon-Inducible Genes

Paula S. Ramos1, Timothy D. Howard2, Miranda C. Marion3, Satria Sajuthi4, Jennifer A. Kelly5, Kathy L. Moser5 and Carl D. Langefeld4, 1Department of Medicine, Medical University of South Carolina, Charleston, SC, 2Center for Genomics and Personalized Medicine Research, Wake Forest School of Medicine, Winston-Salem, NC, 3Department of Biostatistical Sciences, Wake Forest University Health Sciences, Winston-Salem, NC, 4Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, 5Oklahoma Medical Research Foundation, Oklahoma City, OK

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: genomics, methylation and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic, multisystem, autoimmune inflammatory disease. In addition to genetic and environmental influences, the discordance rate between monozygotic (MZ) twins suggests a role for epigenetic factors in disease. The analysis of MZ twins represents the ideal design to assess the role of epigenetic factors in disease etiology. Here, we report the results of a genome-wide analysis of DNA methylation on 3 MZ twin pairs discordant for SLE.

Methods: Genomic DNA was extracted from peripheral blood of 3 MZ twin pairs discordant for SLE. DNA methylation profiling was performed using the Illumina Infinium HumanMethylation450 BeadChip. Probes with a detection P-value<1.0E-05 were excluded. In order to identify differentially methylated genes between unaffected and affected twins, a paired t-test on the probe-specific β-values was computed and significance was assessed as the intersection of meeting an FDR threshold (1.06x10E-7) and mean DNA methylation difference (Δβ)>|0.10|. 

Results: Global hypomethylation of interferon-inducible genes was observed in the affected twins. Analysis of the top loci using Gene Ontology suggested an enrichment of epigenetic changes in genes involved in response to biotic stimulus (GO:0009607; P(Benjamini)=0.0077) and response to virus (GO:0009615; P(Benjamini )=0.021), and their functional annotation using Panther revealed an enrichment of two biological processes, immunity and defense (BP00148; P(Benjamini)=0.0044) and interferon-mediated immunity (BP00156; P(Benjamini)=0.032). The top hypomethylated sites in the affecteds were located in several interferon-inducible genes, including MX1 (Δβ =-0.47, P=6.59E-13), IFI44L (Δβ =-0.29, P=1.58E-14), and IFITM1 (Δβ =-0.25, P=4.41E-40). Other significant loci included the polymerase PARP9 (P=6.74E-126, Δβ =-0.37), the cytidine kinase CMPK2 (Δβ =-0.33, P=7.98E-08), and the cyclic nucleotide phosphodiesterase PDE7A genes (Δβ =-0.35, P=1.21E-09).

Conclusion: These data support a role for DNA methylation differences in mediating susceptibility to SLE. Furthermore, these observed hypomethylation of interferon-inducible genes offers a mechanistic explanation for the well know overexpression of interferon-inducible genes observed in patients with SLE and other autoimmune diseases.


Disclosure:

P. S. Ramos,
None;

T. D. Howard,
None;

M. C. Marion,
None;

S. Sajuthi,
None;

J. A. Kelly,
None;

K. L. Moser,
None;

C. D. Langefeld,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/epigenetic-profiling-in-monozygotic-twins-discordant-for-systemic-lupus-erythematosus-reveals-prominent-hypomethylation-of-interferon-inducible-genes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology